Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
Background: Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether-lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance. Methods: In an ope...
Prif Awduron: | Ashley, E, Stepniewska, K, Lindegardh, N, Mcgready, R, Annerberg, A, Hutagalung, R, Singtoroj, T, Hla, G, Brockman, A, Proux, S, Wilahphaingern, J, Singhasivanon, P, White, N, Nosten, F |
---|---|
Fformat: | Journal article |
Cyhoeddwyd: |
2007
|
Eitemau Tebyg
-
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
gan: Ashley, E, et al.
Cyhoeddwyd: (2007) -
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
gan: Tarning, J, et al.
Cyhoeddwyd: (2009) -
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
gan: Mcgready, R, et al.
Cyhoeddwyd: (2006) -
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
gan: McGready, R, et al.
Cyhoeddwyd: (2009) -
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
gan: van Vugt, M, et al.
Cyhoeddwyd: (2000)